{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05406778",
            "orgStudyIdInfo": {
                "id": "1001"
            },
            "organization": {
                "fullName": "Spark Neuro Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "SPARK Neuro REMIND Study",
            "officialTitle": "SPARK Neuro Quantitative Resting State EEG Protocol for Assessing Cognitive Impairment and AD Status 'REMIND' Study",
            "therapeuticArea": [
                "Other",
                "Neurology"
            ],
            "study": "spark-neuro-remind-study"
        },
        "statusModule": {
            "statusVerifiedDate": "2022-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-05-18",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-05",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-11",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-05-26",
            "studyFirstSubmitQcDate": "2022-06-01",
            "studyFirstPostDateStruct": {
                "date": "2022-06-06",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2022-07-06",
            "lastUpdatePostDateStruct": {
                "date": "2022-07-08",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Spark Neuro Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": true,
            "isUnapprovedDevice": true,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "The study utilizes investigational software, the SPARK Test, with an FDA-cleared electroencephalography (EEG) amplifier and EEG cap to collect and then analyze patient EEG data.",
            "detailedDescription": "The aim of this study is to develop an algorithm and then evaluate it to determine whether applying machine-learning techniques to resting-state electroencephalography (EEG) can characterize patient's cognitive status and detect the presence or absence of AD on the basis of the patient's EEG."
        },
        "conditionsModule": {
            "conditions": [
                "Alzheimer Disease",
                "Cognitive Impairment"
            ],
            "keywords": [
                "EEG",
                "Electroencephalography",
                "Machine learning"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "DIAGNOSTIC",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 800,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "TBD",
                    "type": "OTHER",
                    "interventionNames": [
                        "Device: SPARK Test"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "SPARK Test",
                    "description": "Twenty (20) minutes of resting state EEG data collection.",
                    "armGroupLabels": [
                        "TBD"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Software malfunction occurrences",
                    "description": "Report rate of software malfunction occurrences that resulted in a failure to complete a SPARK Test recording.",
                    "timeFrame": "10 weeks"
                },
                {
                    "measure": "Assessment of patients SPARK Test data",
                    "description": "* Rate of concordance between SPARK Test score of Alzheimer's Disease (AD) label (positive or negative) with clinical diagnosis\n* Rate of concordance between SPARK Test Cognitive Impairment Index (CII) score predictive of Montreal Cognitive Assessment (MoCA score)\n* Rate of concordance between SPARK Test cognitive status label (unimpaired, Mild Cognitive Impairment (MCI), mild dementia, moderate dementia, severe dementia with unimpaired/MCI/dementia labels operationalized by Clinical Dementia Rating (CDR)",
                    "timeFrame": "10 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Mean absolute error for specific cognitive assessment",
                    "description": "Mean absolute error for Alzheimer's disease Assessment Scale - 14-item cognitive sbuscale (ADAS-Cog-14), Alzheimer's Disease Cooperative Study Activities of Daily Living (ADCS-ADL), iADRS, CDR and (Mini-Mental State Exam (MMSE)",
                    "timeFrame": "10 weeks"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Alzheimer's Disease positive vs. negative indication for biomarker-confirmed AD",
                    "description": "Rate of concordance between SPARK Test predicted Alzheimer's Disease positive/negative for biomarker-confirmed AD as measured by CSF-based markers including amyloid-Beta, Tau, phosphorylated-Tau, proteins related to amyloid processing or PET-based imaging.",
                    "timeFrame": "10 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Age 55 to 85 at the time of consent\n2. Informant available and willing (remotely or in-person) to provide information about sleep patterns and cognitive functioning who spends \\>8 hours per week with primary subject\n3. Subject or Legally Authorized Representative (LAR) has the ability to provide informed consent and comply with the protocol.\n\nExclusion Criteria:\n\n1. Unable to remain still for up to 30 minutes during EEG data recording\n2. Subjects currently on and unable to wash out concomitant medications, including: 1) opiates; 2) benzodiazepines and nonbenzodiazepine hypnotics; 3) sedative antihistamines; 4) tricyclic anti-depressants; 5) skeletal muscle relaxants; 6) antiepileptics; 7) antipsychotics; 8) antimanic agents; 9) THC; 10) anticholinergics\n3. Previous history of stroke, severe head injury, craniotomy or any other potentially confounding neurologic illness causing known structural brain damage\n4. Medical or psychiatric illness that would interfere with study participation\n5. History of epilepsy or chronic seizure disorder\n6. Presence of non-dental metal in head\n7. Currently experiencing a skin disease on scalp that would affect electrode contacts\n8. TICS score indicative of cognitive impairment at screening\n9. Substance Use Disorder, including Alcohol",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "55 Years",
            "maximumAge": "85 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Marinela Gombosev",
                    "role": "CONTACT",
                    "phone": "929-515-6003",
                    "email": "study1001@sparkneuro.com"
                },
                {
                    "name": "Che Lucero",
                    "role": "CONTACT",
                    "phone": "929-515-6003",
                    "email": "study1001@sparkneuro.com"
                }
            ],
            "locations": [
                {
                    "facility": "Voyage Medical",
                    "status": "RECRUITING",
                    "city": "Tempe",
                    "state": "Arizona",
                    "zip": "85282",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Crystal Brown",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Ali Imran, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.41477,
                        "lon": -111.90931
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000000544",
                    "term": "Alzheimer Disease"
                },
                {
                    "id": "D000060825",
                    "term": "Cognitive Dysfunction"
                }
            ],
            "ancestors": [
                {
                    "id": "D000003704",
                    "term": "Dementia"
                },
                {
                    "id": "D000001927",
                    "term": "Brain Diseases"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000024801",
                    "term": "Tauopathies"
                },
                {
                    "id": "D000019636",
                    "term": "Neurodegenerative Diseases"
                },
                {
                    "id": "D000019965",
                    "term": "Neurocognitive Disorders"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                },
                {
                    "id": "D000003072",
                    "term": "Cognition Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3885",
                    "name": "Alzheimer Disease",
                    "asFound": "Alzheimer's Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M29705",
                    "name": "Cognitive Dysfunction",
                    "asFound": "Cognitive Impairment",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6904",
                    "name": "Dementia",
                    "relevance": "LOW"
                },
                {
                    "id": "M5204",
                    "name": "Brain Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M23002",
                    "name": "Tauopathies",
                    "relevance": "LOW"
                },
                {
                    "id": "M21558",
                    "name": "Neurodegenerative Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M21836",
                    "name": "Neurocognitive Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M6301",
                    "name": "Cognition Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "T2192",
                    "name": "Familial Alzheimer Disease",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}